Please upgrade your browser.
Axitinib is an oral and selective inhibitor of vascular endothelial growth factor receptors that might play roles in tumor growth and the metastatic progression of cancer.
We characterized the distribution of the different immature and mature myeloid DC subsets in RCC tumour tissue and the corresponding normal kidney tissues.
We estimated standardized incidence ratios (SIRs) with corresponding 95% confidence intervals (CIs) by dividing the number of observed cases of multiple myeloma within the renal cell carcinoma cohort and the number of renal cell carcinoma cases within the multiple myeloma cohort by the number of expected cases for each malignancy in the US general population.
Current RCC pathology reporting fails to satisfy CAP guidelines, does not permit the use of prognostic systems, and may hinder enrollment into adjuvant trials and the selection of systemic therapy
Radiofrequency ablation, sometimes referred to as RFA, is a minimally invasive treatment for cancer. It is an image-guided technique that heats and destroys cancer cells.
Will you help to create greater awareness of kidney cancer and the need for a cure? Learn how you can win $1,000.00 and a FlipVideo camera for helping with this cause.
Reducing Risk Of Recurrence And A Stabilization In Incidence Of Renal Cell Carcinoma Will Limit Growth Of Drug-Treatment Opportunities
Projected improvements in recurrence-free survival and a discontinuation of the historically observed increases in the incidence rate of renal cell carcinoma (RCC) will limit growth of new drug-treatment opportunities for advanced disease in RCC.
The Cancer Nutrition Rehabilitation (cnr) program at the McGill University Health Centre is an interdisciplinary 8-week treatment program offering patients information, education, treatment, and support in areas such as diet, exercise, and rehabilitation, plus resources to address their psychosocial needs.
|Powered by NeonCRM|